Andrews University

Digital Commons @ Andrews University
Faculty Publications

Behavioral Sciences

April 2011

State Methamphetamine Precursor Policies and
Changes in Small Toxic Lab Methamphetamine
Production
Duane C. McBride
Andrews University, mcbride@andrews.edu

Yvonne Terry-McElrath
Jamie Chriqui
Jean O'Connor
Curtis VanderWaal
Andrews University, vanderwa@andrews.edu
See next page for additional authors

Follow this and additional works at: http://digitalcommons.andrews.edu/behavioral-pubs
Part of the Substance Abuse and Addiction Commons
Recommended Citation
McBride, Duane C.; Terry-McElrath, Yvonne; Chriqui, Jamie; O'Connor, Jean; VanderWaal, Curtis; and Mattson, Karen, "State
Methamphetamine Precursor Policies and Changes in Small Toxic Lab Methamphetamine Production" (2011). Faculty Publications. 9.
http://digitalcommons.andrews.edu/behavioral-pubs/9

This Article is brought to you for free and open access by the Behavioral Sciences at Digital Commons @ Andrews University. It has been accepted for
inclusion in Faculty Publications by an authorized administrator of Digital Commons @ Andrews University. For more information, please contact
repository@andrews.edu.

Authors

Duane C. McBride, Yvonne Terry-McElrath, Jamie Chriqui, Jean O'Connor, Curtis VanderWaal, and Karen
Mattson

This article is available at Digital Commons @ Andrews University: http://digitalcommons.andrews.edu/behavioral-pubs/9

© 2011 BY THE JOURNAL OF DRUG ISSUES

STATE METHAMPHETAMINE PRECURSOR POLICIES AND
CHANGES IN SMALL TOXIC LAB METHAMPHETAMINE
PRODUCTION
DUANE C. MCBRIDE, YVONNE M. TERRY-MCELRATH, JAMIE F. CHRIQUI, JEAN C.
O’CONNOR, CURTIS J. VANDERWAAL, KAREN L. MATTSON
Domestic production of methamphetamine in small toxic labs (STLs) results in
significant community safety and health consequences. This paper examines the
effects of state-level policies implemented in the middle of the last decade in reaction
to a rapid increase in STL labs. These policies focused on controlling access to
the methamphetamine precursor chemicals ephedrine and pseudoephedrine and
the relationship of such policies with actual STL seizure rates. Data include (a)
primary legal research on state laws/regulations in all 50 states in effect as of
October 1, 2005; and (b) STL seizure counts for 2004–2006. Results from random
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effects cross-sectional time-series regression models showed that states with the
greatest reduction in STL seizures had comprehensive policies involving quantity
limits on methamphetamine precursor purchases, clerk intervention requirements
(such as requiring buyer identification) and regulatory agency specification for
monitoring compliance and tracking multiple purchases. Criminalizing purchasing
violations was not related to STL reductions.

INTRODUCTION

Research suggests that methamphetamine use relates to high risks of addiction
and abuse (Anglin, Burke, Perrochet, Stamper, & Dawud-Noursi, 2000; Baucum,
Rau, Riddle, Hanson, & Fleckenstein, 2004; National Institute on Drug Abuse
[NIDA], 2006; Volkow et al., 2001), as well as sustained and increased general
and violent criminal behavior (Cartier, Farabee, & Prendergast, 2006; Hansell,
2006; Sommers, Baskin, & Baskin-Sommers, 2006). Methamphetamine use has
significant consequences for community safety and health, including increased
levels of community violence (Kyle & Hansell, 2005) as well as increased risk
of child neglect and abuse (Dube et al., 2003; Mecham & Melini, 2002) and
associated removal of children from homes (Hansell, 2006; Kyle & Hansell, 2005).
The production of methamphetamine has also proven to have significant public
health consequences to communities, especially when produced in small toxic
labs (STL). STL methamphetamine production combines key precursor chemicals
such as pseudoephedrine and ephedrine (found in common cold medications) with
hazardous and often volatile acids, solvents, metals or salts. STLs are generally
defined as laboratories that produce one pound or less of methamphetamine per
cooking cycle, and were estimated to provide approximately 20 percent of the United
States (US) methamphetamine supply in 2006 (O’Connor, Chriqui, & McBride,
2006). Explosives are sometimes planted around STLs to protect the production
unit, and violence is likely to be directed at law enforcement personnel who seize
the lab (Scott & Dedel, 2006).
STL methamphetamine production often occurs in home environments where
significant health consequences related to direct toxic chemical exposure and
related fumes occur. Exposure can result in chemical burns and damage to the
respiratory system as well as a wide variety of neurological and other health-related
consequences for those who live in the environment, with children being particularly
vulnerable to serious harms (Barr et al., 2006; Farst et al., 2007). Rates of child
abuse and neglect are also heightened in STL environments. It is important to note
that these health consequences can continue to affect the next residents of the home
who may not be aware that methamphetamine was produced in the structure they
buy or rent.
First responders (law enforcement, firefighters, emergency medical personnel,
etc.) who participate in an STL seizure or respond to an explosion or fire at a
254
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lab also are at high risk from the toxic compounds used in and resulting from
methamphetamine production (Cooper et al., 2000; McFadden, Kub, & Fitzgerald,
2006). Further, there are continuing health consequences from contamination of
the broader environment including soil, ground water, and any other material in or
near the production site. Environmental contamination can result in long-term, ongoing health consequences for those who come into contact with the contaminated
environment and considerable local costs related to necessary clean-up efforts
(Royal Canadian Mounted Police, 2001). Dobkin and Nicosia (2009) published
a report summarizing methamphetamine production cost estimates in the US for
2005; they noted that methamphetamine production and use has market costs and
consequences similar to those for other illegal drugs. However, methamphetamine
has additional costs of toxic chemicals present in the production environment that
result in considerable health and safety risks. Overall, their best estimate of costs
in 2005 was $23,384,400.
Data from the Drug Enforcement Agency’s national Clandestine Laboratory
Seizure System (CLSS) documented a large increase in the number of US
methamphetamine STLs in the early 2000s as such labs spread quickly from West to
East. The CLSS reported 6,777 methamphetamine STL seizures in 1999, increasing
to 8,577 in 2001 and 10,015 in 2004 (National Drug Intelligence Center [NDIC],
2005; 2006). Given the widespread geographic increase in the distribution of STLs
in the early 2000s and the consequences of domestic methamphetamine production
and use, states and the federal government undertook major efforts to restrict access
to over-the-counter medications and other products that contain methamphetamine
chemical precursors.
O’Connor and her colleagues (O’Connor, Chriqui, & McBride, 2006; O’Connor
et al., 2007) documented the wide variety of policy approaches taken by states to
restrict access to methamphetamine precursor products. Anecdotal reports and
congressional testimony indicated that significant decreases in STL seizures followed
the enactment of these precursor policies (Office of National Drug Control Policy
[ONDCP], 2006; Rutledge, 2004; Wright, 2004). However, there has not been a
comprehensive multi-state quantitative analysis relating enacted state legislation
or adopted regulations (hereafter referred to as state policies) with STL seizure
rates. The current paper aims to contribute to the literature by investigating two
primary research questions. First, is there evidence that STL seizure rates decreased
significantly following state and federal policy changes implemented between
January 2004 and October 1, 2005? Second, is there evidence that differences
exist between states in the relative effectiveness of specific precursor policy
environment? This time period, immediately after the implementation of major
varying comprehensive policies in many states provided a unique opportunity to
FALL 2011
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examine changes in STL seizures related to specific policy elements as well as
changes in states that did not implement these types of policies.
METHODS
DATA SOURCES

Two main data sources were used: (1) state policies related to methamphetamine
precursors in effect as of October 1, 2005; and (2) methamphetamine-related STL
seizure data from 2004-2006.
STATE POLICY DATA

State methamphetamine precursor policies (including statutory and administrative
laws) in effect as of October 1, 2005, were obtained by The MayaTech Corporation
from Westlaw and state government websites using primary legal research methods
(Mersky & Dunn, 2002). A detailed description of the state methamphetamine
precursor policy data including data collection methodology can be found elsewhere
(O’Connor et al., 2007). The October 1, 2005 reference date was chosen to allow
for pre-/post-analyses linking the state policy data with the STL seizure data for
2004 and 2006. Due to resource limitations, we were only able to capture one state
policy reference date. The October 1, 2005 date was chosen as it allowed for at least
one year of post-implementation-related STL seizure data and at least one year of
pre-implementation data in states without such policies prior to this date. Although
not ideal from a policy “lagged” effect perspective, one year of post-policy seizure
data was considered to be suitable for this study given available anecdotal and
documented information from the field describing an almost immediate impact of
precursor policies on reductions in STL seizures (ONDCP, 2006; Rutledge, 2004;
VanderWaal et al., 2008; Wright, 2004).
State-specific effective dates for all policies were obtained as part of the policy
data collection process. In other words, although policy data reflected laws in effect
as of October 1, 2005, individual policy provisions identified the specific effective
dates when the provisions became effective (see Appendix A for state citations and
effective dates). The provision-level effective dates enabled the pre/post policy
analyses described below.
STL SEIZURE DATA

Methamphetamine-related STL seizure data for all states from 2004-2006 were
obtained from the CLSS housed at the El Paso Intelligence Center (EPIC). CLSS
data are based on a voluntary reporting system, and include only those seizures
reported to EPIC by contributing agencies. Although reported seizures may not
fully reflect total seizures nationwide, a number of steps were taken to ensure, as
far as possible, the use of reliable data (see below).
256
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DATA PREPARATION

Working with EPIC personnel, a series of steps were used to organize the CLSS
data for analysis. First, ten states were excluded either due to known problems with
data reporting or low seizure frequency due to regional location (primarily New
England states) where the methamphetamine STL problem did not appear to have
yet significantly developed (Connecticut, Delaware, Massachusetts, Maryland,
Maine, New Hampshire, New Jersey, Rhode Island, Texas, and Vermont). Second,
a comparison of CLSS data with Community Oriented Policing Services (COPS)
data was employed in order to evaluate CLSS data reporting quality. COPS data
includes counts of the number of times toxic site clean-up funds from COPS are
requested by a state. For calendar year 2006, the count of COPS requests per state
was compared with the number of seizures reported in the CLSS data. As not every
lab seizure would be expected to require clean-up funding, the number of CLSS
seizures should approximately meet or exceed the number of COPS clean-up requests
per state. Eight states do not primarily rely on COPS data for clean-up, or use COPS
grants and thus were not compared (California, Hawaii, Kansas, Kentucky, Maryland,
Missouri, North Dakota, and Washington). A minimum threshold of 75% agreement
was used, and resulted in exclusion of an additional eight states (Alaska, Louisiana,
Minnesota, New Mexico, South Carolina, Tennessee, Utah, and West Virginia). Thus,
the following 32 states were retained for analysis because they would provide the
most reliable data for comparison of state methamphetamine precursor policies and
trends in STL seizures: Alabama, Arizona, Arkansas, California, Colorado, Florida,
Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan,
Mississippi, Missouri, Montana, Nebraska, Nevada, New York, North Carolina,
North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota, Virginia,
Washington, Wisconsin, and Wyoming.
Following state selection, CLSS data were sorted by lab capacity and lab type.
Seizures of labs with production capacity of 10 pounds per cooking cycle or higher
(termed “super labs”) were removed. Data were then organized by lab type to ensure
that only methamphetamine-related lab seizures were included (anhydrous ammonia,
hydriodic acid, ice conversion, methamphetamine, methcathinone [included as it
requires the same ephedrine/pseudoephedrine precursors as methamphetamine],
P2P/methylamine, tablet extraction, and urine extraction labs) (Amera-Chem, Inc.,
2004). A total of 39,923 seizure incidents during 2004 through 2006 in the 32 states
remained for analysis.
Next, the coded state precursor policy data were merged with the seizure incidentlevel CLSS data. An indicator variable was created to identify if a seizure occurred
at any point following the relevant state’s policy change effective date. The decision
to create an “any” lag variable was predicated on the anecdotal evidence indicating
FALL 2011
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an immediate impact of state laws on reductions in STL seizures as well as evidence
from the relationship between other types of drug and substance control policies
and behavior change that indicated both immediate and intermediate (3-years or
less) impacts on behavior change (Bundy, 2004; Colby, 2004; Fuller, Rieckmann,
McCarty, Ringor-Carty, & Kennard, 2006; Levy, 2007; Rutledge, 2004; Wright,
2004). Data were then aggregated into bi-monthly counts of STL seizures per state,
resulting in an N of 2,304 (72 cases per state). Each case (i.e., each bi-monthly count
of STL seizures per state) was then coded as being pre/post policy implementation.
At least 50 percent of the seizures in the relevant bi-monthly time period were
required to have occurred after the specific policy was implemented in order to be
coded as post-policy implementation.
CONSTRUCTS AND MEASURES
OUTCOME MEASURE

For all analyses, the outcome measure was the bi-monthly count of STL seizures
per state (described above). Given the strong positive skew of the measure, analytical
models utilized natural log transformation of the original variable (a constant of 1
was added to all cases before conducting the transformation, as some cases had 0
seizures).
INDEPENDENT MEASURES: STATE POLICY TYPES AND STATE POLICY CHANGE DATE INDICATOR

Based on initial exploratory models, we chose to focus on four policy areas
that were most likely to relate to STL seizure counts: (a) retail transaction quantity
restrictions, (b) sales environment restrictions, (c) purchase and possession
penalties, and (d) agency responsible for enforcing precursor policies. Individual
policies within each of the four areas noted above were then explored for evidence
of relationships with STL seizure counts. Results showed that states appeared to
enact bundled policy provisions. For example, if a state enacted a policy requiring
photo identification (ID) when purchasing products containing pseudoephedrine or
ephedrine, it was also likely to require that the precursors be available only behind
the counter. After further examining the data, the following state policy types were
identified:
Clerk intervention and quantity/packaging restrictions (separate variables for
both ephedrine and pseudoephedrine): Clerk intervention was defined as at least
one of the following: product located behind counter, buyer signature required in
a separate clerk logbook, photo ID required, sales to minors prohibited. Quantity/
packaging restrictions were defined as “any” restrictions. These variables were
combined to form one four-level ordinal measure: 0=neither clerk intervention nor
quantity/packaging restrictions; 1=no clerk intervention, but have quantity/packaging
258
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restrictions; 2=have clerk intervention, but no quantity/packaging restrictions;
3=have both clerk intervention and quantity/packaging restrictions.
Buyer purchase offense severity (separate variables for both ephedrine and
pseudoephedrine): 0=non-crime, 1=crime (misdemeanor or felony).
Specification of sales regulatory/enforcement agency: 0=no such specification;
1=agency specified. For example, the policy might state that the state police were
responsible for monitoring and enforcing sales violations.
We examined the effective dates by state for the policy types identified above.
Some states had pre-existing policies (effective prior to January 2004). Almost all
states that enacted policy change between January 2004 and October 1, 2005 did
so at a single point in time, most often combining more than one policy type and
sometimes specifying the same policy provisions for both pseudoephedrine and
ephedrine (only Wisconsin had two separate methamphetamine precursor policyrelated effective dates). Because of this complex state policy change environment,
it was not possible to meaningfully model differences in individual policy type
change dates. Thus, a single dichotomous indicator variable was created identifying
each case of bi-monthly seizures as pre- or post-policy change effective date (for
Wisconsin, the first policy change date was used; the second effective date occurred
only 45 days following the first, and no substantive differences were found based
on use of the first or second change date). Cases occurring prior to the effective date
were coded as 0, while cases were coded as 1 if at least 50 percent of the seizures
occurred following the state policy change effective date.
A 13-level categorical variable was then created to identify states by type of
policy change approach (see the Results section for further details). This variable
was created to examine the robustness of results for the state policy change indicator
across policy environment change types.
INDEPENDENT MEASURES: FEDERAL POLICY INDICATORS

O’Connor and colleagues (O’Connor, Chriqui, & McBride, 2006) point out that
policy activity directed at limiting access to methamphetamine precursor chemicals
has not been limited to the state level. While a variety of historical federal policies
have been in place, two specific policy provisions took effect during our study time
period (i.e., 2004-2006) that could be expected to relate directly to STL seizure
rates in the current models. These policies were both included in the Combat
Methamphetamine Epidemic Act (Combat Methamphetamine Epidemic Act ,
2006) (see Appendix A for citation information and effective dates for both state
and federal policies):
Federal purchase quantity limits: 0=prior to policy; 1=restrictions for non-liquid
pseudoephedrine sold to individuals (effective April 8, 2006).
FALL 2011
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Federal clerk intervention requirement: 0=prior to policy; 1=requirements to place
methamphetamine precursor products behind the counter or in locked cabinets at
the point of sale, photo ID, retailer logbook of all sales, and staff training (effective
September 30, 2006).
It is important to note that federal policy did not preempt more restrictive state
policies. However, in recognition of the possible impact of federal laws on the
relationship between state methamphetamine precursor laws/regulations and STL
seizures, analytical models included indicators variables for both federal provisions
(based on their effective dates) identified above. Clearly, only a very small number
of cases in the current study occurred following the federal clerk intervention
requirement. Thus, models controlled for the federal clerk intervention policy change
indicator, but results will not be reported because estimates are not expected to be
suitably reliable. In contrast, as 24 percent of cases in the current study occurred
following the implementation of the federal purchase quantity limits (see Table 1),
obtained estimates will be reported for this policy measure.
ANALYTICAL MODELS

Given the panel nature of the data and the pre-existing trend in STL seizures,
analyses were conducted using Stata v10.1 and specifying xtregar to fit random
effects cross-sectional time-series regression models with a first-order autoregressive
disturbance using the GLS estimator (StataCorp LP, 2007). Analyses to answer
the first research question (looking for evidence that STL seizure rates decreased
significantly following state and federal policy changes) were modeled using
variations of the following equation:

where y = the number of seizures for state i at time t; υ is the state-specific
residual, and ε is the first-order autoregressive disturbance term
Models were estimated in the following order: Model 1 included only the state policy
change indicator; Model 2 added both federal policy change indicators; Model 3
added state fixed effects. A second series of analyses were then estimated using Model
3 but grouping by state policy bundle type (i.e., testing to see if the policy change
indicators remain significant across policy bundle types). Following this, all models
were again estimated restricting the data to include only time periods occurring
prior to October 1, 2005, in order to avoid time periods during which additional
state policies may have been implemented but which were not captured due to the
October 1, 2005 state policy data collection cut-off (these models necessarily did
not include federal policies, which had not yet been implemented).
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Analyses to answer the second research question (if differences existed between
states in the relative effectiveness of specific precursor policy environment)
were estimated using a similar equation to that specified above (Model 3) but
substituting the following sets of policy environment predictors for the dichotomous
state change indicator: (a) ephedrine clerk intervention and quantity packaging
restrictions, ephedrine buyer purchase offense severity, regulatory/enforcement
agency specification; or (b) pseudoephedrine clerk intervention and quantity
packaging restrictions, pseudoephedrine buyer purchase offense severity, regulatory/
enforcement agency specification.
RESULTS

As noted previously, a total of 2,304 cases representing bi-monthly seizure counts
for 32 states were included in analyses. Table 1 indicates that over the 2004-2006
period of study, the mean number of seizures per bi-monthly time period was 17.3
(overall standard deviation (SD) 24.4), with a range of 0 to 213. Both betweenand within-state variance were significantly greater than zero (SDbetween=20.4;
SDwithin=13.8); indicating that seizure rates differed strongly both between states
and within states over time. This is presented graphically in Figures 1 and 2. Figure
1 shows that, for all states, STL bi-monthly seizure counts dropped from a high
of 1,117 in early 2004 to 212 at the end of December 2006. The strong decreasing
trend is likely attributable to a variety of factors including social trends and preexisting policy differences. Analyses discussed below investigated if policy changes
implemented during the study time period contributed significantly to seizure rate
trends.
Figure 2 shows the strong differences in STL seizure rates between those states
with and without any state methamphetamine precursor policy changes during the
time period of the current study. As noted in the Introduction, STL manufacture of
methamphetamine has experienced significant geographic variance. It is important
to note that public safety and health consequences often precede (and result in)
legislative action. Figure 2 shows that states with methamphetamine precursor
policy changes had significantly higher levels of STL seizures. At least in the case
of methamphetamine precursor policy, change appears to have been driven by the
need to address existing problems related to STL methamphetamine manufacture
(vs. implementing policy as a purely preventive measure).
The overall distribution of cases by policy change date indicator can be found
in Table 1. Thirty-nine percent of cases occurred following the first or only state
policy change effective date (between January 2004 and October 1, 2005). As noted
previously, Wisconsin was the only state to have a second policy change effective
date (only 2% of cases occurred following this date). Twenty-four percent of cases
occurred following the effective date of federal purchase quantity limits on nonFALL 2011
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TABLE 1. DESCRIPTIVES
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FIGURE 1. TOTAL METHAMPHETAMINE-RELATED SMALL TOXIC LAB SEIZURES IN 32
RETAINED STATES, 2004-2006
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FIGURE 2. TOTAL METHAMPHETAMINE-RELATED SMALL TOXIC LAB SEIZURES FROM
2004-2006 IN RETAINED STATES WITH NO STATE PRECURSOR POLICIES
(AS OF OCTOBER 1, 2005) VERSUS STATES WITH POLICIES BECOMING EFFECTIVE
BETWEEN JANUARY 1, 2004 AND OCTOBER 1, 2005

liquid pseudoephedrine sold to individuals, and eight percent occurred following
the effective date of federal clerk intervention policy.
Table 2 presents the types of state policy changes grouped in change type bundles
that were observed in the current study, as well as showing the mean seizures and
number of states associated with each bundle group. Seven states had no pre-existing
policies and did not implement any prior to October 1, 2005. Two states (California
and Arizona) had pre-existing policies, but did not change or add policies between
264
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TABLE 2. STATE METHAMPHETAMINE PRECURSOR POLICY CHANGE GROUPINGS, 2004–2006

January 2004 and October 1, 2005. Two additional states (Alabama and Mississippi)
implemented changes in all included policies between January 2004 and October 1,
2005. The remaining 21 states implemented a change in at least one but not all of the
precursor policies between January 2004 and October 1, 2005. It is important to note
that some of these states had at least one implemented policy prior to January 2004.
The overall distribution of cases by the type of state policy environment can
be found in Table 1. Over half of all cases occurred when a state had neither clerk
intervention nor quantity/packaging restrictions for either ephedrine (64%) or
pseudoephedrine (55%) by the October 1, 2005 state policy cut-off date. Just over
10 percent of cases occurred in a policy environment where quantity/packaging
restrictions were in place without clerk intervention (11% for ephedrine; 13% for
pseudoephedrine); very few cases occurred in policy environments where clerk
intervention was in place but not quantity/packaging restrictions (4% for both
ephedrine and pseudoephedrine). A higher percentage of cases occurred in policy
environments where both clerk intervention and quantity/packaging restrictions
were in place for pseudoephedrine (28%) than ephedrine (20%). Approximately 23
percent of cases occurred in policy environments where the penalty for purchasing
pseudoephedrine or ephedrine was classified as a crime (either misdemeanor or
felony). Finally, 31 percent of cases occurred where states had specified an agency
for regulatory/enforcement activities regarding methamphetamine precursor sales.

FALL 2011
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TABLE 3. TIME SERIES REGRESSION RESULTS FOR DIFFERENCES IN METHAMPHETAMINE
SMALL TOXIC LAB SEIZURE RATES BY ANY POLICY CHANGE, 2004–2006

PRE- AND POST-PRECURSOR POLICY STL SEIZURE RATE CHANGES

Table 3 shows results of models examining rates of STL seizures for all
32 included states by both state and federal precursor policy implementation
indicators. Rates of STL seizures decreased significantly following state policy
change implementation, and this decrease was significant after controlling for both
federal policy implementation as well as state fixed effects (see results for Model
3). Results also show that the federal purchase quantity policy implementation date
was also independently associated with decreased seizure rates both before and after
controlling for state fixed effects (see results for Model 3). When analyses were
re-estimated restricting the sample to only cases occurring prior to the October 1,
2005 policy coding cut-off date, the direction and significance level of results for
both state and federal policy change indicators did not change (results not shown).
Table 4 presents results of analyses seeking to explore if the significance of the
state policy change date was robust across different state policy change approaches.
266
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TABLE 4. TIME SERIES REGRESSION RESULTS FOR DIFFERENCES IN METHAMPHETAMINE
SMALL TOXIC LAB SEIZURE RATES BY ANY STATE POLICY CHANGE, MODELED SEPARATELY
BY POLICY CHANGE BUNDLE, 2004–2006

See page 268 for Table 4 notes.
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TABLE 4. TIME SERIES REGRESSION RESULTS FOR DIFFERENCES IN METHAMPHETAMINE
SMALL TOXIC LAB SEIZURE RATES BY ANY STATE POLICY CHANGE, MODELED SEPARATELY
BY POLICY CHANGE BUNDLE, 2004–2006 (CONTINUED)
Notes: All models controlling for federal clerk intervention change indicator and state fixed effects
(results not reported). Outcome is the natural log of bi-monthly counts of STL seizures, with a
constant of 1 added to all cases.
A. No changes; no pre-existing policies
B. No changes; pre-existing policies
C. Pseudoephedrine clerk intervention and quantity/packaging restriction policy change
D. Pseudoephedrine clerk intervention and quantity/packaging restriction policy change;
specification of regulatory/enforcement agency policy change
E. Pseudoephedrine and ephedrine clerk intervention and quantity/packaging restriction policy
change
F. Pseudoephedrine and ephedrine clerk intervention and quantity/packaging restriction
changes; specification of regulatory/enforcement agency policy change
G. Pseudoephedrine and ephedrine clerk intervention and quantity/packaging restriction
change; pseudoephedrine and ephedrine purchase severity policy change
H. Changes in all noted policies
I. Category includes 4 states, each of which was the only state to implement their specific type
of policy change. Policy changes included:
(1) specification of regulatory/enforcement agency;
(2) pseudoephedrine clerk intervention and quantity/packaging restriction;
pseudoepherine purchase severity; specification of regulatory/enforcement agency;
(3) pseudoephedrine and ephedrine clerk intervention and quantity/packaging
restriction; ephedrine purchase severity;
(4) ephedrine clerk intervention and quantity/packaging restriction; specification of
regulatory/enforcement agency
*p<.05; **p<.01; ***p<,001
a Restrictions for non-liquid pseudoephedrine sold to individuals.
ρar: Estimated autocorrelation coefficient.
σu: State-level standard deviation (between states)
σe: Standard deviation of bi-monthly time periods (within states)
ρfov: Fraction of variance between states
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Separate models were estimated for all policy change environments in which at
least two states utilized the same change bundle. As single-state models cannot be
estimated using a cross-sectional time series model, the four states that implemented
unique policy change approaches were combined in one model. Results show that
regardless of the state policy change bundle, STL seizure rates decreased significantly
following state policy change implementation. Analyses were re-estimated in models
restricting the sample to only cases occurring prior to the October 1, 2005 policy
cut-off date. While the significance level for Policy Bundle E dropped from p<.001
to p<.01 in these models, the direction and significance level of all other results
did not change.
Table 4 shows that the significance of the implementation of federal policy
did vary across the different state policy groupings. Implementation of federal
quantity restrictions were not related to seizure rates in the following state groups:
(1) three states implementing changes in pseudoephedrine clerk intervention and
quantity/packaging restrictions, as well as specification of regulatory/enforcement
agency; (2) three states implementing changes in pseudoephedrine and ephedrine
clerk intervention and quantity/packaging restrictions, as well as specification of
regulatory/enforcement agency; (3) two states implementing changes in all noted
policies.
BETWEEN-STATE DIFFERENCES IN STL SEIZURE RATES BY POLICY ENVIRONMENT

The results of the analyses presented above indicate that statistically significant
reductions in STL seizures occurred following the implementation of policies
directed at controlling access to products containing the methamphetamine precursor
chemicals ephedrine and pseudoephedrine. We now turn to focusing on betweenstate differences in STL seizure rates by overall policy environment with models
controlling for the a priori highly significant differences in STL seizure rates between
states. Results of these analyses are presented in Table 5.
States with any type of clerk intervention or quantity/packaging restrictions
showed lower rates of STL seizures than did states without such policies (for both
ephedrine and pseudoephedrine). While the specific clerk intervention approach
taken for ephedrine did not appear to significantly relate to seizure rates, the
same was not true for pseudoephedrine. STL seizure rates were higher in states
with pseudoephedrine quantity/packaging restrictions only compared to states
with quantity/packaging restrictions combined with clerk intervention provisions
(coefficient 0.2249; p<.05; data not shown). No difference in seizure levels between
states was observed based on whether or not the state had criminal penalties for
purchasing violations of either ephedrine or pseudoephedrine precursor policies.
However, STL seizure rates were significantly lower in states that specified an
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agency for regulatory/enforcement responsibilities. Federal policy implementation
continued to be related to decreased STL seizures.
DISCUSSION

In the last few decades, there has been considerable discussion regarding the
specific roles of federal and state governments in establishing policy related to the
public’s health, including policy related to substance use. Some perceive that such
policy is exclusively a federal affair, while others believe state governments should
be the main actors in such policy development. One area in which both states and
the federal government have had significant recent policy development activity deals
with reducing the significant criminal justice and public-health concerns resulting
from STL methamphetamine production and use.
The data documents that states took a wide variety of approaches toward reducing
access to the methamphetamine precursor chemicals ephedrine and pseudoephedrine.
From January 1, 2004 through October 1, 2005, 72 percent (23) of the 32 states
included in the current study implemented some type of change in policy focusing
on either (a) controlling the quantity of ephedrine/ pseudoephedrine-containing
product sales, (b) the required form (if any) of clerk intervention at the point of
purchase, (c) the definition of precursor policy purchasing violations as a crime,
or (d) specifying a regulatory agency to oversee enforcement of the state’s policy.
All of the state policy changes noted above occurred prior to changes in federal
policy specifying non-liquid pseudoephedrine quantity limits as well as defining
methamphetamine precursor chemical clerk intervention policies. Such variance
over time allowed us to develop models aimed at examining pre/post policy changes
in methamphetamine STL seizures, as well as comparisons of STL seizure rates
between methamphetamine precursor policies.
This paper set out to examine two research questions: (1) Is there evidence that
STL seizure rates decreased significantly following state and federal policy changes
implemented between January 2004 and October 1, 2005? (2) Is there evidence that
differences exist between states by type of specific methamphetamine precursor
policy environment? The results from the analyses indicate that the answers to
both research questions are affirmative. STL seizure rates decreased significantly
following state and federal policy change effective dates, both overall and across
different state policy change groups. This consistent decline in methamphetamine
STL seizures soon after the implementation of state and federal precursor policies
is a finding consistent with media reports (Associated Press, 2006), qualitative
research (VanderWaal et al., 2008), and conclusions by the U.S. Department of
Justice (NDIC, 2005).
Results also indicated that some state policies related strongly to decreases in
STL seizures (clerk intervention and quantity/packaging restrictions; specification
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of a regulatory/enforcement agency) while others (purchase penalty severity) did
not. As discussed in the introduction, there is literature that indicates a decrease in
STL seizures after the implementation of general policies attempting to limit access
to methamphetamine precursor chemicals. However, little research has focused on
specific policy elements. In this paper, within-state analyses found that states which
restricted the quantity of ephedrine/pseudoephedrine sales, or required some form of
clerk intervention, were more likely to report significant reductions in STL seizures
following policy implementation. This suggests that restricting precursor chemicals
via quantity restrictions likely relates to less availability, which in turn relates to
a reduced ability to manufacture methamphetamine in STLs. In pseudoephedrine
models, combining quantity restrictions with the requirement for some type of
clerk intervention (requiring photo ID or locating the product behind the counter)
was associated with significantly reduced STL seizures compared with quantity/
packaging restrictions alone. This finding suggests that for pseudoephedrine--the
substance with higher direct consumer access in the local retail environment--clerk
intervention plays a key role in reducing access for STL manufacturers.
One of the policies examined in quantitative models was whether or not
states identified an agency that was responsible for enforcing/regulating enacted
methamphetamine precursor policies. As of October 1, 2005, only 11 of the 32
retained states’ policies identified a regulatory agency responsible for enforcement
and implementation. Identification of an agency to oversee the implementation of
their methamphetamine precursor sales policies was associated with significant
reductions in STL seizures. The data suggest it may not be sufficient merely
to enact policies that restrict access to dangerous chemicals; mechanisms for
reporting violations and regulating compliance must also be in place. There is some
indication in the media (Bovett, November 16, 2010:A31) and in discussions with
law enforcement, that due to the lack of precursor sales tracking in many states,
“smurfing” (users going from store to store and buying the limit of pseudoephedrine
in each store) continues at a relatively high rate.
One of the most common policies used in attempts to reduce the production,
distribution or use of illegal drugs involves the enactment of severe criminal
penalties. This approach is based on classic deterrence theory that argues that if
penalties are sufficiently severe, the behavior will be less likely to occur (Mendes
& McDonald, 2001). However, results show that, controlling for the relative
impact of other policies, criminal penalties for purchase were not associated with
significantly reduced STL seizure rates. This may suggest that, at least in regards
to STL seizures, penalty policies for purchase do not appear to have as much of
a deterrent effect on STL rates as do policies restricting and enforcing access to
ephedrine/pseudoephedrine.
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Perhaps one of the most important findings in the current paper is that, overall,
both state and federal policies matter. In almost all of the analytical models,
significant decreases in STL seizure rates were associated with the implementation
date of the federal policy focusing on non-liquid pseudoephedrine quantity limits
after controlling for state policy. Alternately, the implementation date of state
precursor policy changes was also associated with decreases in STL seizure rates after
controlling for federal policy. It is important to remind readers that changes in state
policy occurring after October 1, 2005, were not included in analytical models. Thus,
it is possible that findings related to federal policy may, in some way, be associated
with unmeasured state policy changes. However, the data indicate that both federal
and state policies are an important part of a comprehensive approach directed at
reducing the consequences and harms associated with illicit drug production and
use. Federal law may help prevent the purchasing of large quantities of precursor
chemicals in one state and then, following transporting of the materials across state
lines, manufacturing methamphetamine in states with existing precursor policies.
Further, while federal law was less stringent that some state policies, it may have
also provided an important minimum purchasing standard and penalties for states
that had not yet enacted any precursor laws.
The analyses presented in this paper suggest that both the states and the
federal government took a measured and complex approach to reducing STL
methamphetamine production. Purchase quantity controls, combined with clerk
intervention and having a regulatory agency responsible for policy implementation
and monitoring of purchases, consistently related to reductions in STL lab seizures in
both within- and between-state analyses. These data suggest that there is not a simple
approach to addressing an issue such as the domestic production of methamphetamine
in STLs. However, a combination of policies appears to have related to significant
reductions in the domestic STL production of methamphetamine. It remains to be
seen if this reduction in STL labs is related to a reduction in methamphetamine use,
quality, or purity (Royal Canadian Mounted Police, 2001). Further, it is unknown
if these observed policy relationships will continue over time or if STL operators
will eventually resume prior production levels. Such an increase might well occur
if resources are not available to continue active efforts to reduce STL production, or
if existing policies are not enforced through a regulatory agency using an integrated
data system capable of recording and tracking precursor purchases.
The findings of this study should be considered within their limitations. The
source for the outcome measure for these analyses is the CLSS data which, as
noted previously, are voluntarily reported data. Thus, CLSS data are not necessarily
reported with equal accuracy across states or within states across time. However, the
CLSS data remain the only extant data source on US illicit drug laboratory seizures,
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and are a primary source of information for the US Department of Justice (Dobkin
& Nicosia, 2009). As the authors worked closely with EPIC personnel and COPS
comparisons to include only those states with the highest data quality, the resulting
data is believed to be the best currently available. Readers should also recognize
that the analyses focused only on how the examined policies relate to STL seizure
reductions. Analyses examining how such policies relate to the prevalence of
methamphetamine use in the community, or to reductions in costs borne by local,
state, and federal governments resulting from STL clean-up efforts and/or hospital
and treatment costs, were not within the scope of these analyses. It is also important
to note that Dobkin and Nicosia (2009) indicated that methamphetamine markets
have tended to recover fairly rapidly from attempts to interrupt supply. This may
suggest the continued importance of further policy developments to address changing
production markets. For example, recent epidemiological evidence indicates a shift in
local methamphetamine production to what is known as the “one pot” or “shake and
bake” method. This method involves smaller laboratories and lessened amounts of
precursors (and smaller quantities of produced methamphetamine) thereby lessening
the likelihood of detection (National Institute on Drug Abuse, 2010). Further, state
policies enacted and effective after the October 1, 2005 policy cut-off date were
beyond the scope the analyses, but would prove important in future research as
would analyses of longer-term impacts of the policies on reductions in STL seizures.
Small toxic labs present significant environmental and health-related dangers and
costs to communities. Data presented in this paper indicate that many states have
developed policies that do, indeed, appear to have related to rapid and significant
declines in the production of methamphetamine in STLs. The data also suggest that
a comprehensive federal and state approach that includes designated regulatory
agencies that can enforce precursor policies focusing on quantity controls, clerk
intervention, and a regulatory system than monitors precursor chemical purchases
are crucial policy elements in efforts to reduce the number of STLs that manufacture
methamphetamine in the US and their associated harms.
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